Clinical TrialID 5220
Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab
NCT01393821
Dermatologic Complications|Malignant Neoplasm|Pain
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5220
- Evidence Id
- 5220
- Core Evidence Id
- 5220
- Source Clinical Trial Id
- 5202
- Herb2 Clinical Trial Id
- HBCT005202
- Nct Id
- NCT01393821
- Title
- Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab
- Status
- Active_Not_Recruiting
- Phase
- Study Result
- Yes
- Study Condition
- Dermatologic Complications|Malignant Neoplasm|Pain
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: menadione topical lotion|OTHER: placebo|OTHER: questionnaire administration|PROCEDURE: management of therapy complications
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 27
- Outcome Measure
- Change From Baseline to Week 4 Face Pain Score Measuring Cutaneous Discomfort, Change from baseline to Week 4 Face pain score measuring cutaneous discomfort. Face pain scale question ("How would you describe how your face feels?") with a 0-10 Face Pain Scale, where 0 = No pain/burning and 10 = worst possible pain/burning., From Baseline to Week 4
- Sponsor Collaborator
- Mayo Clinic|National Cancer Institute (NCI)
- Funded By
- OTHER
- Location
- Mayo Clinic Campus in Arizona, Phoenix, Arizona, 85054, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States
- Other Id
- MC10C9|NCI-2011-01047|11-001566|R21CA134432
- Start Date
- 2012-01-23
- Primary Completion Date
- 2013-05-11
- Completion Date
- 2025-03-31
- First Posted
- 2011-07-13
- Results First Posted
- 2019-10-16
- Last Update Posted
- 2024-05-03
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01393821
- Title Cn
- Title En
- Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab
- Bilingual Status
- semi_complete